Alpana Naresh

Alpana Naresh, Ph.D. is currently the Executive Director, CMC Operations at Harpoon Therapeutics, overseeing the CMC Operations of the company's novel trispecific Tri-TACs early stage clinical products. With experience in protein science, process development, and clinical study coordination, Alpana has held various roles at companies such as Boehringer Ingelheim Fremont, Inc., JSR Micro Inc., Sutro Biopharma, and Genitope. Alpana's educational background includes a Ph.D. in Biotechnology from the Institute of Microbial Technology in Chandigarh, India, and a Master of Science in Biotechnology from CCS Haryana Agricultural University in Hisar, India.